| Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients (NCT04213794) | Mayo Clinic | 2019-11-08 |
| Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors (NCT03420963) | M.D. Anderson Cancer Center | 2018-08-31 |
| Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma (NCT01861301) | National Cancer Institute (NCI) | 2013-01-01 |
| Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma (NCT01503177) | Mayo Clinic | 2011-11-01 |
| Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (NCT01126346) | Wake Forest University Health Sciences | 2010-05-01 |
| AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma (NCT01105390) | National Cancer Institute (NCI) | 2010-04-01 |
| Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma (NCT01064648) | National Cancer Institute (NCI) | 2010-03-15 |
| Pazopanib in Treating Patients With Malignant Pleural Mesothelioma (NCT00459862) | National Cancer Institute (NCI) | 2007-03-01 |
| Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma (NCT00392444) | National Cancer Institute (NCI) | 2007-02-01 |
| PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery (NCT00365053) | National Cancer Institute (NCI) | 2006-06-01 |
| Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery (NCT00309946) | National Cancer Institute (NCI) | 2005-12-01 |
| Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma. (NCT00107432) | National Cancer Institute (NCI) | 2004-10-01 |
| Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung (NCT00039182) | National Cancer Institute (NCI) | 2002-05-01 |
| Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction (NCT00030498) | National Cancer Institute (NCI) | 2001-12-01 |
| Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma (NCT00027703) | National Cancer Institute (NCI) | 2001-10-01 |
| EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer (NCT00028782) | National Cancer Institute (NCI) | 2001-10-01 |
| Gefitinib in Treating Patients With Malignant Mesothelioma (NCT00025207) | National Cancer Institute (NCI) | 2001-09-01 |